Evaluation of automated single mass spectrometry to tandem mass spectrometry function switching for comprehensive drug profiling analysis using a quadrupole time-of-flight mass spectrometer
Tn. Decaestecker et al., Evaluation of automated single mass spectrometry to tandem mass spectrometry function switching for comprehensive drug profiling analysis using a quadrupole time-of-flight mass spectrometer, RAP C MASS, 14(19), 2000, pp. 1787-1792
A liquid chromatographic mass spectrometric strategy for systematic toxicol
ogical analysis (STA) is presented using the automatic 'on-the-fly' single
mass spectrometry mode to tandem mass spectrometry mode (MS to MS/MS) switc
hing abilities of a quadrupole time-of-flight (Q-TOF) instrument. During th
e chromatographic run, the quadrupole is initially set to transmit all mass
es until (an) ion(s) reaches a certain set threshold. Thereupon, the quadru
pole automatically switches to the MS/MS mode, selecting the ion(s), which
are subsequently fragmented in the high-efficiency hexapole collision cell,
thus generating product ions that are further mass analyzed by the TOF. By
limiting the TOF spectral accumulation time in the MS/MS mode to a statist
ically acceptable minimum, the quadrupole almost instantly switches back to
the MS mode. Qualitative information, comprising the complementary MS ([M
+ H](+) ion mass) and MS/MS (informative product ion profile) data, as well
as quantitative information obtained by integration of the MS extracted io
n chromatogram(s), can be obtained in one single acquisition. Optimization
of the automatic switching parameters, such as threshold, TOF spectral accu
mulation time, detection window and collision energy, was carried out by in
jection of a mix of 17 common drugs which were not necessarily baseline sep
arated in the chromatographic system used. Indeed, the complete separation
of the drugs is not deemed necessary since up to 8 different ions can 'simu
ltaneously' be selected for MS/MS if they reach the preset criteria. In add
ition, the quantitative performance of the method was defined. In a second
phase, the developed method was field-tested. To that end, the resulting da
ta from extracts of urine samples were compared with and found to be in clo
se concordance with those obtained by a standard toxicological analysis. Th
is innovative approach clearly holds the potential for a substantial advanc
e in the introduction of LC/MS in STA, Copyright (C) 2000 John Wiley & Sons
, Ltd.